We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
Read MoreHide Full Article
Walgreens Boots Alliance (WBA - Free Report) closed at $68.36 in the latest trading session, marking a +0.95% move from the prior day. This change outpaced the S&P 500's 0.86% gain on the day. Meanwhile, the Dow gained 1.14%, and the Nasdaq, a tech-heavy index, added 0.38%.
Prior to today's trading, shares of the largest U.S. drugstore chain had lost 19.99% over the past month. This has lagged the Retail-Wholesale sector's loss of 7.03% and the S&P 500's loss of 7.55% in that time.
WBA will be looking to display strength as it nears its next earnings release, which is expected to be March 27, 2019. On that day, WBA is projected to report earnings of $1.74 per share, which would represent year-over-year growth of 0.58%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $34.63 billion, up 4.88% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $6.52 per share and revenue of $137 billion. These totals would mark changes of +8.31% and +4.15%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for WBA. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.27% lower within the past month. WBA currently has a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that WBA has a Forward P/E ratio of 10.38 right now. This represents a no noticeable deviation compared to its industry's average Forward P/E of 10.38.
We can also see that WBA currently has a PEG ratio of 1.06. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Retail - Pharmacies and Drug Stores stocks are, on average, holding a PEG ratio of 1.06 based on yesterday's closing prices.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 108, putting it in the top 42% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow WBA in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
Walgreens Boots Alliance (WBA - Free Report) closed at $68.36 in the latest trading session, marking a +0.95% move from the prior day. This change outpaced the S&P 500's 0.86% gain on the day. Meanwhile, the Dow gained 1.14%, and the Nasdaq, a tech-heavy index, added 0.38%.
Prior to today's trading, shares of the largest U.S. drugstore chain had lost 19.99% over the past month. This has lagged the Retail-Wholesale sector's loss of 7.03% and the S&P 500's loss of 7.55% in that time.
WBA will be looking to display strength as it nears its next earnings release, which is expected to be March 27, 2019. On that day, WBA is projected to report earnings of $1.74 per share, which would represent year-over-year growth of 0.58%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $34.63 billion, up 4.88% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $6.52 per share and revenue of $137 billion. These totals would mark changes of +8.31% and +4.15%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for WBA. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.27% lower within the past month. WBA currently has a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that WBA has a Forward P/E ratio of 10.38 right now. This represents a no noticeable deviation compared to its industry's average Forward P/E of 10.38.
We can also see that WBA currently has a PEG ratio of 1.06. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Retail - Pharmacies and Drug Stores stocks are, on average, holding a PEG ratio of 1.06 based on yesterday's closing prices.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 108, putting it in the top 42% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow WBA in the coming trading sessions, be sure to utilize Zacks.com.